Complex I deficiency in Parkinson's disease frontal cortex

[1]  J. Parks,et al.  A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. , 1989, The New England journal of medicine.

[2]  Y. Kagawa,et al.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.

[3]  J. Parks,et al.  Mitochondrial ND5 mutations in idiopathic Parkinson's disease. , 2005, Biochemical and biophysical research communications.

[4]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[5]  J. Parks,et al.  Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particles. , 1994, Archives of biochemistry and biophysics.

[6]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[7]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[8]  R. Benecke,et al.  Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. , 1993, Brain : a journal of neurology.

[9]  S. Lipton,et al.  Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Cassio Pennachin,et al.  Genetic algorithm for analysis of mutations in Parkinson's disease , 2005, Artif. Intell. Medicine.

[11]  C. Marsden,et al.  Mitochondrial function in Parkinson's disease , 1992, Annals of neurology.

[12]  N. Howell,et al.  An example of Leber hereditary optic neuropathy not involving a mutation in the mitochondrial ND4 gene. , 1990, American journal of human genetics.

[13]  M. Yahr,et al.  Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease , 1994, Journal of neural transmission. Parkinson's disease and dementia section.

[14]  J. Cooper,et al.  Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease , 1998, Annals of neurology.

[15]  H. Reichmann,et al.  Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.

[16]  D. Wallace,et al.  A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy. , 1989, The New England journal of medicine.

[17]  A. Torroni,et al.  Mitochondrial oxidative phosphorylation defects in parkinson's disease , 1991, Annals of neurology.

[18]  Richard J. Miller.  Mitochondria – the kraken wakes! , 1998, Trends in Neurosciences.

[19]  Anthony H.V. Schapira,et al.  Platelet mitochondria function in Parkinson's disease , 1992 .

[20]  C. Marsden,et al.  Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.

[21]  Robert Hill,et al.  Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.

[22]  H. Yoshino,et al.  Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[23]  W. Nicklas,et al.  Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium , 1986, Journal of neurochemistry.

[24]  S. Kish,et al.  Mitochondria in Alzheimer's disease. , 2002, International review of neurobiology.

[25]  J. Parks,et al.  High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging , 2004, Neurobiology of Aging.

[26]  R. Swerdlow,et al.  Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.